MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Research

Home
Research
haemoglobin

Haemoglobin as Source of Iron Deposits in MS

MStranslate
December 14, 2016
Research
Iron deposits in the brain can be toxic and they have been suggested to be a possible cause of the damage seen in multiple sclerosis (MS). New research from Imperial College London (UCL) has shed more light...
Epstein-Barr Virus

MS & Epstein-Barr Virus Update – Part 2

MStranslate
November 24, 2016
Epstein-Barr virus, Infection, Research, Understanding Science
Research Summary: EBV Infection and Multiple Sclerosis: Lessons from a Marmoset Model Earlier in the week, we discussed the background information about the potential role of Epstein-Barr Virus (EBV) and...
Epstein-Barr Virus

MS & Epstein-Barr Virus Update – Part 1

MStranslate
November 21, 2016
Epstein-Barr virus, Infection, Research, Understanding Science
3 Comments
Today, we are presenting Part 1 of a two-part update on a role for Epstein-Barr Virus (EBV) in multiple sclerosis (MS).  This first part is going to focus on the evidence of why people think that a link may...
MitoQ

MitoQ & Mitochondrial Dysfunction in MS

MStranslate
November 12, 2016
Research
Research Summary: MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis The...
Monoclonal Antibodies

Monoclonal Antibodies for MS Treatments

MStranslate
October 20, 2016
Research, Understanding Science
By Brett Drummond What’s in a name? I was recently asked a question:  “Why do all of the new MS drugs end in mab?  Does that mean something?”.  The answer is yes and it’s probably worth...
MS progression

Rates of MS Progression: Dr Tomas Kalincik (MSBase)

MStranslate
October 11, 2016
Q&A, Research
Upon his return from ECTRIMS 2016, Dr Tomas Kalincik from the Melbourne Brain Centre at Royal Melbourne Hospital spoke to MStranslate about recently published research by MSBase investigators.  Their...
Clinically Stable MS

Clinically Stable MS & Magnetic Resonance Imaging

MStranslate
October 3, 2016
Neuroimaging, Research
What is clinically stable multiple sclerosis? As most of you might be aware, the most common form of multiple sclerosis is relapsing-remitting MS (RRMS).  In RRMS, people may go through periods of attacks...
ECTRIMS 2016

ECTRIMS 2016: An Overview of Key Outcomes

MStranslate
September 22, 2016
Conferences, ECTRIMS, Research, Social Media
Each year, the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) holds the largest MS research meeting in the world.   In 2016, this event was held in London, England, between...
high-dose biotin

High-dose Biotin Clinical Trial Results

MStranslate
September 13, 2016
Biotin, Clinical Trials, Research, Treatments
1 Comment
Research Summary: MD1003 (high-dose biotin) for the treatment of multiple sclerosis: A randomised, double-blind, placebo-controlled study The background Whilst many treatments are now available for...
gene mutation

New Studies Question Gene Mutation Link to MS

MStranslate
September 12, 2016
Genetics, Research
The results of an MS genetic study published in Neuron earlier this year are now being called into question. You may remember that MStranslate did a summary on this article and interviewed the lead researcher,...
  1. 12
  2. 13
  3. 14
  4. 15
  5. 16
  6. 17
  7. 18

Recent Posts

  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS

Recent Comments

  • MStranslate on Multiple Sclerosis Research In 2026
  • MStranslate on Multiple Sclerosis Research In 2026
  • K on Multiple Sclerosis Research In 2026
  • Mohammad on Multiple Sclerosis Research In 2026
  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date

Calendar

October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Sep    

Archives

Categories

Posts

  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.